Ethica Global Investments completed the acquisition of a minority stake in RP Group (Regenyal Laboratories and Phitogen Beauty Labs).

Ethica Global Investments, specializing in supporting Italian SMEs, completed the acquisition of a minority stake in RP Group, a company focused on hyaluronic acid-based medical devices. Financial terms were not disclosed. "We are excited about the partnership with Ethica Global Investments, which will drive a new phase of growth with a stronger brand and an even more extensive international presence," Claudio Bartolomei, RP Group, CEO.